Table 1. Baseline and Hospitalization Characteristics of the Patients With Telephone Assessment.
| No./total (%) | |||
|---|---|---|---|
| All patients (n = 478) | No ambulatory visit (n = 301) | Attended the ambulatory visit (n = 177) | |
| Age, mean (SD), y | 60.9 (16.1) | 63.4 (17.2) | 56.9 (13.2) |
| Women | 201 (42.1) | 133 (44.2) | 68 (38.4) |
| Men | 277 (57.9) | 168 (55.8) | 109 (61.6) |
| Body mass index, mean (SD) [No.] | 28.8 (5.6) [351] | 28.5 (5.9) [186] | 29.1 (5.4) [165] |
| Comorbidities | |||
| Hypertension | 225 (47.1) | 150 (49.8) | 75 (42.4) |
| Obesity | 130/351 (37.0) | 63/186 (33.9) | 67/165 (40.6) |
| Diabetes | 128 (26.8) | 76 (25.2) | 52 (29.4) |
| Chronic heart disease | 77 (16.1) | 63 (20.9) | 14 (7.9) |
| Respiratory disease (other than COPD) | 75 (15.7) | 45 (15.0) | 30 (16.9) |
| Chronic kidney disease | 51 (10.7) | 34 (11.3) | 17 (9.6) |
| Declared psychiatric disorder | 42 (8.8) | 30 (10.0) | 12 (6.8) |
| Neurodegenerative disorder | 34 (7.1) | 32 (10.6) | 2 (1.1) |
| Alcohol misuse | 21/450 (4.7) | 12/282 (4.3) | 9/168 (5.4) |
| Active cancer | 18 (3.8) | 15 (5.0) | 3 (1.7) |
| Other immunosuppression | 18 (3.8) | 11 (3.7) | 7 (4.0) |
| COPD | 17 (3.6) | 12 (4.0) | 5 (2.8) |
| Long-term dialysis | 17 (3.6) | 11 (3.7) | 6 (3.4) |
| HIV infection | 12 (2.5) | 9 (3.0) | 3 (1.7) |
| Solid organ transplantation | 9 (1.9) | 5 (1.7) | 4 (2.3) |
| Liver disease | 7 (1.5) | 2 (0.7) | 5 (2.8) |
| Pregnancy | 5 (1.0) | 3 (1.0) | 2 (1.1) |
| Bone marrow transplantation | 2 (0.4) | 2 (0.7) | 0 |
| Smoking | |||
| No (<5 pack-years) | 343/452 (75.9) | 214/283 (75.6) | 129/169 (76.3) |
| Former (≥5 pack-years) | 83/452 (18.4) | 58/283 (20.5) | 25/169 (14.8) |
| Active | 26/452 (5.8) | 11/283 (3.9) | 15/169 (8.9) |
| Specific treatments | |||
| Azithromycin | 120 (25.1) | 67 (22.3) | 53 (29.9) |
| Tocilizumab (anti–IL-6) | 37 (7.7) | 10 (3.3) | 27 (15.3) |
| Hydroxychloroquine | 32 (6.7) | 14 (4.7) | 18 (10.2) |
| Corticosteroids | 24 (5.0) | 17 (5.6) | 7 (4.0) |
| Lopinavir/ritonavir | 16 (3.3) | 8 (2.7) | 8 (4.5) |
| Anakinra (anti–IL-1RA) | 11 (2.3) | 3 (1.0) | 8 (4.5) |
| Remdesivir | 5 (1.0) | 2 (0.7) | 3 (1.7) |
| Vasopressors | 74 (15.5) | 23 (7.6) | 51 (28.8) |
| Active anticoagulation (at full therapeutic dose) | 75 (15.7) | 26 (8.6) | 49 (27.7) |
| Pulmonary embolism during hospitalization | 41 (8.6) | 12 (4.0) | 29 (16.4) |
| Acute kidney injury during hospitalization | 95 (19.9) | 53 (17.6) | 42 (23.7) |
| Hospitalization in ICU | 142 (29.7) | 45 (15.0) | 97 (54.8) |
| Duration of ICU stay, median (IQR), d | 9 (4-19) | 6.5 (4-15) | 9 (4-22) |
| Total duration of hospitalization, median (IQR), d | 9 (4-15) | 8 (4-12) | 13 (6-23) |
Abbreviations: COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; IQR, interquartile range.